Immune Checkpoint Inhibitors — Competitive Intelligence Brief

Immune Checkpoint Inhibitors (Immune Checkpoint Inhibitors) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Immune checkpoint inhibitor. Area: Oncology.

marketed Immune checkpoint inhibitor Oncology Small molecule

Target snapshot

Immune Checkpoint Inhibitors (Immune Checkpoint Inhibitors) — The Central Hospital of Lishui City. Immune checkpoint inhibitors block inhibitory signals on T cells, allowing the immune system to recognize and attack cancer cells.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Immune Checkpoint Inhibitors TARGET	Immune Checkpoint Inhibitors	The Central Hospital of Lishui City	marketed	Immune checkpoint inhibitor
Cisplatin / Carboplatin，Gemcitabine，Cindilimab	Cisplatin / Carboplatin，Gemcitabine，Cindilimab	People's Hospital of Quzhou	marketed	Combination chemotherapy with immune checkpoint inhibitor	DNA (platinum agents, gemcitabine); PD-L1 (cindilimab)
IN-C006 Peri inj.	IN-C006 Peri inj.	HK inno.N Corporation	phase 3	Immune checkpoint inhibitor	PD-1
GTX-104	GTX-104	Grace Therapeutics Inc.	phase 3	Immune checkpoint inhibitor	PD-1
HL-040XC	HL-040XC	HanAll BioPharma Co., Ltd.	phase 3	Bispecific antibody; immune checkpoint inhibitor
Neoadjuvant ipilimumab + nivolumab	Neoadjuvant ipilimumab + nivolumab	The Netherlands Cancer Institute	phase 3	Immune checkpoint inhibitor combination	PD-1 and CTLA-4
HL301(Experimental)	HL301(Experimental)	Hanlim Pharm. Co., Ltd.	phase 3	Immune checkpoint inhibitor	PD-1/PD-L1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Immune checkpoint inhibitor class)

1. Sun Pharma Advanced Research Company Limited · 2 drugs in this class
2. Brenda Cooper, MD · 1 drug in this class
3. Grace Therapeutics Inc. · 1 drug in this class
4. EMS · 1 drug in this class
5. GERCOR - Multidisciplinary Oncology Cooperative Group · 1 drug in this class
6. Glycotope GmbH · 1 drug in this class
7. Bristol-Myers Squibb · 1 drug in this class
8. HK inno.N Corporation · 1 drug in this class
9. Hanlim Pharm. Co., Ltd. · 1 drug in this class
10. Assistance Publique - Hôpitaux de Paris · 1 drug in this class